OrthogenRx Revenue and Competitors
Estimated Revenue & Valuation
- OrthogenRx's estimated annual revenue is currently $8.5M per year.
- OrthogenRx's estimated revenue per employee is $251,000
Employee Data
- OrthogenRx has 34 Employees.
- OrthogenRx grew their employee count by 3% last year.
OrthogenRx's People
Name | Title | Email/Phone |
---|---|---|
1 | SVP, Operations and Compliance | Reveal Email/Phone |
2 | Regional Account Executive Distributor Partner | Reveal Email/Phone |
3 | Regional Account Executive | Reveal Email/Phone |
OrthogenRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $73.5M | 302 | 26% | N/A | N/A |
#2 | $7M | 23 | 0% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 35 | 17% | N/A | N/A |
#6 | $56.2M | 121 | -18% | N/A | N/A |
#7 | $38.9M | 137 | 10% | N/A | N/A |
#8 | $22.1M | 85 | 18% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is OrthogenRx?
OrthogenRx, Inc. is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA). Headquartered in Doylestown, PA, we are an early stage private medical device company. Our first product, GenVisc® 850 (sodium hyaluronate), is the only five injection hyaluronic acid product produced from non-avian source material.
keywords:N/AN/A
Total Funding
34
Number of Employees
$8.5M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 34 | 0% | N/A |
#2 | $2.7M | 34 | 13% | N/A |
#3 | $3.9M | 34 | 3% | N/A |
#4 | $8.4M | 35 | 6% | N/A |
#5 | $5.6M | 35 | 9% | N/A |